Stock IRIX IRIDEX CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News IRIDEX Corporation

Equities

IRIX

US4626841013

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-17 pm EDT 		5-day change 1st Jan Change
3.18 USD -2.75% Intraday chart for IRIDEX Corporation -1.55% +13.17%
Mar. 26 Transcript : IRIDEX Corporation, Q4 2023 Earnings Call, Mar 26, 2024
Mar. 26 Earnings Flash (IRIX) IRIDEX CORPORATION Reports Q4 Revenue $12.5M, vs. Street Est of $14.9M MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Iridex: Q4 Earnings Snapshot
AQ
Transcript : IRIDEX Corporation, Q4 2023 Earnings Call, Mar 26, 2024
Earnings Flash (IRIX) IRIDEX CORPORATION Reports Q4 Revenue $12.5M, vs. Street Est of $14.9M
MT
IRIDEX Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Iridex Reports Fourth Quarter and Full Year 2023 Financial Results
GL
IRIDEX Corporation Reports Earnings Results for the Fourth Quarter Ended December 30, 2023
CI
North American Morning Briefing : Markets Steady -2-
DJ
Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024
GL
Iridex Corporation Receives European Patent on MicroPulse Technology
GL
Iridex Corporation Receives European Patent on MicroPulse Technology
AQ
Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust
GL
Iridex Corporation Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust
CI
Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma
GL
Iridex Corporation Launches New Iridex 532 and Iridex 577 Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma
CI
Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation
GL
Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation
GL
Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation
AQ
Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation
CI
Iridex: Q3 Earnings Snapshot
AQ
Transcript : IRIDEX Corporation, Q3 2023 Earnings Call, Nov 14, 2023
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IRIX Stock
  4. News IRIDEX Corporation